Objective:

To explore the molecular mechanisms mediating endocrine control of folliculogenesis and oocyte maturation, emphasizing the importance of these mechanisms in improving patient-centered reproductive care.

Key Findings:

• GnRH agonist trigger shows superior safety profile compared to hCG, reducing risk of OHSS, which is crucial for patient safety.
• Endocrine modulation via FSH priming may improve maturation metrics without enhancing broader reproductive outcomes, indicating the need for careful evaluation of treatment protocols.
• PCOS is a systemic disorder linked to long-term metabolic dysfunction, necessitating integrated treatment approaches that consider both reproductive and metabolic health.

Interpretation:

The findings emphasize the need for individualized treatment strategies in reproductive endocrinology, balancing efficacy and safety while considering metabolic health, and providing actionable insights for clinical practice.

Limitations:

• Translational relevance of preclinical findings in PCOS remains uncertain, highlighting the need for further research.
• Variability in PCOS phenotypes complicates treatment approaches, necessitating tailored strategies for different patient profiles.

Conclusion:

Optimizing endocrine strategies in ART requires a focus on patient-centered outcomes rather than solely on intermediate metrics, integrating considerations of metabolic health into treatment plans.